Research > ETFs > ETF / ETP Commentary > 

Rethinking Equal Weight: How RAFI Offers an Alternative

As equity market concentration hits historic levels, investors are actively seeking alternative index weighting strategies to mitigate idiosyncratic risk. For decades, the default option to escape the confines of market-capitalization concentration was to seek refuge in equal-weight strategies. By assigning a fixed, uniform weight to every index constituent, an equal-weight strategy decouples a company’s portfolio allocation from its market capitalization. That said, is an equal-weight strategy the only approach to reducing volatility? The RAFI Fundamental Index offers an alternative approach as discussed in Winning the Long Game with RAFI.Key Takeaways: As an alternative to an equal-weighting approach, the RAFI Fundamental Index addresses market-cap concentration by disconnecting stock prices from portfolio weighting and anchoring allocations directly to economic scale. By selecting and weighting constituents using metrics like sales, cash flow, and dividends, the methodology preserves large-cap liquidity while systematically stripping out single-stock valuation hype and small-cap volatility. Through quarterly staggered rebalancing across four tranches, the strategy limits turnover and reduces transaction costs, delivering a superior risk-adjusted return profile over naive equal weighting. See More: Winning the Long Game with RAFIFlaws of Equal WeightingA one-size-fits-all approach to equal weighting carries hidden structural flaws. While it succeeds at diluting mega-cap concentration, it does so mechanically without taking into account a company’s overall size and contribution to the economy. The RAFI Fundamental Index offers a different approach. Frequently conceptualized as a modified or smart equal-weight strategy, RAFI addresses concentration risk by first disconnecting price from portfolio weight. But rather than assigning each company an identical weight, the methodology determines allocations based on tangible economic scale rather than mathematical equality. As mentioned, a traditional market-capitalization-weighted portfolio anchors its holdings strictly to stock price. According to RAFI Indices, this results in a massive weighted average market capitalization of $1.39 trillion as well as a negative size-factor tilt. Conversely, a naive equal-weight index relies on a mechanical formula that assigns an identical weight to every stock regardless of size, which causes its weighted average market capitalization to plunge to $127 billion, creating a strong positive size-factor tilt while driving index implementation costs higher. RAFI bridges these two approaches by anchoring portfolio weights directly to its economic footprint. This methodology maintains a robust weighted average market capitalization of $769 billion, keeps size-factor exposure neutral or negative, and preserves trading efficiency. The RAFI approach also maintains meaningful exposure to large-cap liquidity while systematically stripping out valuation exuberance.Economic Rationale vs. Naive SizingRAFI Indices notes that a standard equal-weight index like the S&P 500 Equal Weight Index allocates 0.20% to every constituent. This, in effect, treats a selection universe much like an egalitarian society where all occupations are paid the same regardless of their contributions to the general populace. In the parlance of indexing, this means treating a multinational enterprise generating hundreds of billions in revenue identically to a smaller firm with a fraction of that economic footprint. From the view of an equal weighted index, Apple and MarketAxess Holdings deserve the same allocation, even though Apple has 500 times the revenue! Ultimately, weighting implicitly assumes that every company deserves the same share of allocation. Conversely, RAFI selects and weights companies based on financial metrics. This includes adjusted sales, book value plus intangibles, operating cash flow, and dividends plus buybacks. RAFI ensures that a stock’s portfolio weight reflects its actual contribution to global economic activity. Additionally, fundamental weighting avoids unintended small-cap exposure. Equal-weight strategies force a heavy, implicit bet on lower-capitalization equities, exhibiting positive size-factor loadings across global markets, such as 0.07 in the U.S., 0.26 in Developed ex-U.S., and 0.28 in Emerging Markets. As mentioned previously, RAFI maintains a neutral-to-negative size exposure, preventing this unintended bet on inherently volatile small caps.Reduced Volatility and Superior Risk-Adjusted ReturnsBecause equal-weight strategies allocate heavily down the market-capitalization spectrum into smaller, more volatile companies, they carry higher total risk. In the U.S. market, an equal-weight portfolio exhibits approximately 10% higher annualized volatility compared to the RAFI Fundamental US Index. When evaluated through a risk-adjusted lens, fundamental weighting delivers significantly better Sharpe ratios across international equities. Domestically, RAFI achieves a Sharpe ratio that is more than 50% higher relative to equal weighting. Similarly, in emerging markets, RAFI delivers a Sharpe ratio that is also more than 50% higher than its equal-weighted counterpart. Across developed ex-U.S. equities, RAFI continues to outperform by achieving a roughly 20% higher Sharpe ratio. By avoiding the volatility of small-cap equities, RAFI preserves the diversification benefits of non-price weighting while maintaining portfolio stability. An example of this reduced volatility at work is comparing the Invesco RAFI US 1000 ETF (PRF A-) to the Invesco Russell 1000 Equal Weight ETF (EQAL A). Looking at the volatility profiles of both funds (as of September 23, 2026), PRF has less volatility year to date (YTD), the last 12 months, three years, five years, and 10 years. Moreover, in terms of annualized total return, PRF has also been the stronger performer within those same time periods.Execution Efficiency Via Staggered RebalancingAdditionally, equal-weighted strategies face persistent implementation challenges. To prevent portfolio weights from drifting back toward capitalization-weighting, equal-weight indexes must perform full rebalances more frequently. RAFI mitigates these friction costs through two key structural mechanisms. First, by once again weighting companies according to their economic footprint, capital naturally flows to larger, highly liquid securities that are cheaper to trade. Second, through its QSR methodology, RAFI avoids executing a full portfolio rebalance on a single calendar day. Instead, the index is divided into four equal tranches, and only one tranche is rebalanced toward target fundamental weights each quarter. In effect, QSR diversifies entry point risk, reduces market impact, and lowers transaction costs. RAFI limits annual turnover, leading to estimated transaction impact costs of 0.01% compared to 0.16% for equal weighting.A Superior Core FoundationIn the end, equal-weight strategies highlight the structural issues related to market-capitalization indexing. Relying strictly on market price creates concentration risk and over-allocates to overvalued equities. While an equal-weighted approach can address over-allocation risks, a blind approach introduces unintended small-cap bets, higher volatility, and elevated trading costs. By anchoring portfolio weights to economic footprints and utilizing staggered rebalancing, the RAFI Fundamental Index mitigates concentration risk inherent in an equal weighting approach, but through a more cost-efficient framework. For more news, information, and strategy, visit the Smart Beta Content Hub. VettaFi LLC (“VettaFi”) is the index provider for PRF, for which it receives an index licensing fee. However, PRF is not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of PRF.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.